Cancer Research SABCS  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 166-169, February 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buiatti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buiatti, M.

The Induction of Tumors in the Hybrid Nicotiana glauca x N. langsdorffii Plants by 6-Azauracil and Its Reversal by Uracil and Actinomycin D1

M. Buiatti2

Biology Department, Brookhaven National Laboratory, Upton, New York 11973

Azauracil was found to be the only one of several analogs of nucleic acid precursors tested in these studies which is capable of inducing tumors at a very early stage during seedling development in the genetically tumor-conditioned hybrid Nicotiana glauca x N. langsdorffii. Tumor induction by 6-azauracil was shown to be reversed by simultaneous treatments with uracil and actinomycin D as well as by posttreatments. Pre-treatments with the same substances proved to be ineffective.

The possible implications of the findings in view of the possible involvement of an abnormal species of RNA in the process of tumor induction by 6-azauracil are discussed.

1 Research performed at Brookhaven National Laboratory under the auspices of the U. S. Atomic Energy Commission.

2 Present address: Instituto di Genetica dell'Universita, Pisa, Italy.

Received 4/ 6/67. Accepted 9/29/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.